Gemcitabine 1400mg Injection

Gemcitabine 1400mg is an antimetabolite chemotherapy used in pancreatic, non-small-cell lung, bladder, breast and ovarian cancer regimens. It is often combined with another anticancer medicine for the specific tumour type.
The reconstituted and diluted dose is usually infused into a vein over about 30 minutes on scheduled treatment days. Extending infusion time or increasing treatment frequency can increase toxicity.
Gemcitabine is converted into active nucleotides that reduce DNA building blocks and become incorporated into DNA, preventing further tumour-cell replication.
Low blood counts, nausea, fatigue, fever, rash and flu-like symptoms can occur. Serious lung injury, kidney-related haemolytic uraemic syndrome and capillary leak are uncommon but important.
Blood counts, kidney and liver tests guide treatment. Report new breathlessness, reduced urine output or unusual swelling. Timing relative to radiotherapy matters because tissue reactions may be intensified.
Can reduce cancer-cell growth and help control symptoms within an appropriate combination regimen.
Blood counts or other toxicities can require omission or delay of an individual treatment day without changing the entire treatment goal.
Yes, flu-like symptoms can occur, but fever still needs prompt assessment to rule out infection.
Longer exposure can increase toxicity; the infusion duration is part of the regimen rather than a flexible comfort setting.
No. A powder vial is identified by the total amount of gemcitabine. The prepared concentration depends on the reconstitution and dilution steps.
Antimetabolite: a medicine that disrupts cellular building blocks. Reconstitution: adding a suitable liquid to a powder medicine. Haemolytic uraemic syndrome: red-cell breakdown associated with kidney injury.; AR: Gemcitabine 1400mg حقن; FR: Gemcitabine 1400mg injection; PT: Gemcitabine 1400mg injeção; ES: Gemcitabine 1400mg inyección; RU: Gemcitabine 1400mg инъекция; ID: Gemcitabine 1400mg suntikan; VI: Gemcitabine 1400mg thuốc tiêm; MS: Gemcitabine 1400mg suntikan; TL: Gemcitabine 1400mg iniksyon; ZH-SG: Gemcitabine 1400mg 注射剂
International B2B Enquiry
Send a structured B2B enquiry for Gemcitabine 1400mg Injection under Oncology Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Gemcitabine 1400mg Injection